PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Activity
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-5
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
DCM
1
DAFNA Capital Management
California
$0
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$0
3
HLA
3
Hamilton Lane Advisors
Pennsylvania
$0
4
IIA
4
IPG Investment Advisors
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
1
DAFNA Capital Management
California
– -$9.69K -321,856 Closed
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
– -$4K -172,958 Closed
HLA
3
Hamilton Lane Advisors
Pennsylvania
– -$1K -34,208 Closed
IIA
4
IPG Investment Advisors
California
– -$864 -28,700 Closed